ArcBest Corporation (ARCB) 70.8 +0.43 (+0.61%)
70.8 +0.43 (+0.61%)
US03937C1053 - Common Stock - After market: 70.8 0 (0%)
Buy % Consensus
Analysts have set a mean price target of 121.89. This target is 72.16% above the current price.
ARCB was analyzed by 16 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ARCB.
In the previous month the buy percentage consensus was at a similar level.
ARCB was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-06-28 | Credit Suisse | Initiate | Outperform |
| 2022-05-18 | Morgan Stanley | Maintains | Overweight |
| 2022-04-08 | B of A Securities | Downgrade | Buy -> Neutral |
| 2022-03-09 | B of A Securities | Maintains | Buy |
| 2022-02-02 | Goldman Sachs | Maintains | Neutral |
| 2021-11-09 | Morgan Stanley | Maintains | Overweight |
| 2021-10-19 | B of A Securities | Maintains | Buy |
| 2021-10-05 | Truist Securities | Maintains | Buy |
| 2021-10-04 | Morgan Stanley | Maintains | Overweight |
| 2021-09-30 | Cowen & Co. | Maintains | Outperform |
| 2021-07-14 | Citigroup | Maintains | Buy |
| 2021-06-29 | Truist Securities | Maintains | Buy |
| 2021-06-08 | Vertical Research | Upgrade | Hold -> Buy |
| 2021-06-07 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2021-06-04 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2021-05-27 | Morgan Stanley | Maintains | Overweight |
| 2021-04-15 | Truist Securities | Maintains | Buy |
| 2021-03-26 | Vertical Research | Initiate | Hold |
| 2021-03-25 | Morgan Stanley | Maintains | Overweight |
| 2021-02-17 | Morgan Stanley | Maintains | Overweight |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA